Virtus LifeSci Biotech Products ETF
18 hedge funds and large institutions have $6.16M invested in Virtus LifeSci Biotech Products ETF in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.45% more ownership
Funds ownership: 16.78% → 17.22% (+0.45%)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$470K | |
| 2 | +$225K | |
| 3 | +$223K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$120K |
| 5 |
JPMorgan Chase & Co
New York
|
+$85K |